chronic inflammatory demyelinating polyneuropathy (cidP) is the most common acquired immune-mediated inflammatory disorder of the peripheral nervous system. The diagnosis is based in classic cases, on the distribution pattern of the neurologic semiology, and pathologic changes of nerve conduction studies (NcS). however, in cases with subtle clinical presentation, an extended diagnostic workup may be needed (cerebrospinal fluid examination, laboratory tests, nerve biopsy). NcS remain fundamental for the diagnosis, follow up, and measurement of response to immune-treatment in cidP. however, new challenges arose on how best to acquire a static and dynamic imaging of the peripheral nerves, with the aim of providing a holistic approach to the nerve impairment. according to the literature, neuromuscular ultrasound is able to detect in cases of cidP thickened or swollen roots, peripheral nerves, or brachial plexus, findings that are consistent with ongoing inflammation. This review provides a timely update on the nerve ultrasound findings of cidP and future possibilities of neuromuscular ultrasound are also discussed. 
These findings may be further supported with evidence of cytoalbuminologic dissociation in cerebrospinal fluid analysis, but this is not obligatory for the diagnosis. 6 different criteria, such as inflammatory Neuropathy cause and Treatment (iNcaT), american academy of Neurology (aaN), and Saperstein, can be used to define the disease. 7, 8 While nowadays NcS remain fundamental to confirm the presence, pattern, and severity of this type of polyradiculoneuropathy, 6 new challenges have arisen recently in terms of how to acquire the best static and dynamic imaging of the relevant nerve structures in cidP, with the aim of providing a complementary and holistic approach to nerve impairment.
using magnetic resonance imaging (MRi), various hypertrophic changes have been demonstrated in peripheral nerves, roots, or brachial plexus in studies on cidP patients. [9] [10] [11] [12] [13] [14] although MRi is an accurate diagnostic method in imaging soft tissues, it has the disadvantages of being expensive, timeconsuming, affected by artefacts (e.g. metal), and not practical, especially when a number of nerves need to be examined over a long course in patients with polyneuropathy. The role of neuromuscular ultrasound in the diagnostic workup of cidP and polyneuropathies, in general, remains less well defined and parallels the beginnings of research of entrapment neuropathies. only a few studies in the literature have used ultrasound to examine the pathologic changes in immune-mediated neuropathies, highlighting mainly pathologic changes of the cross-sectional area (cSa) of peripheral nerves and their correlation with clinical and electrophysiologic findings. [15] [16] [17] [18] [19] [20] [21] This review provides an update on the diagnostic role of neuromuscular ultrasound in the diagnostic of cidP, while possible future possibilities of neuromuscular ultrasound are also discussed. 29 and (4) the intraplexus cSa variability defined as: maximal cSa of the brachial plexus/minimal cSa of the brachial plexus (see Table 1 ). 
Quantification of Ultrasound Findings in

Ultrasound Findings
currently 10 studies (evaluating a total of 74 cases) on nerve sonography in cidP patients have been published (see Table 2 ). The first description of the sonographic findings in cidP was published from Taniguchi et al. 30 in this report, the authors documented a brachial plexus hypertrophy on both sides and peripheral nerve hypertrophy at several sites of the median, sciatic and femoral nerve. Similar findings had only been reported in MRi studies until then. 9-14 a possible explanation of the documented hypertrophy (see The same observation was made in three cases of multifocal acquired demyelinating sensory and motor neuropathy (MadSaM). 20, 21 Systematic data on the sensitivity and specificity of sonography as a screening method of immune therapy do not exist. 
Conclusions
